The following information is missing from the Funding section: Supported in part by National Eye Institutes research grant EY 21727; Mayo Foundation, Rochester, MN; and Research to Prevent Blindness, Inc., New York, NY (MPF is a recipient of a Lew R. Wasserman Merit Award and the Department of Ophthalmology, Mayo Clinic is the recipient of an unrestricted grant).
Reference
- 1. Roy Chowdhury U, Bahler CK, Holman BH, Dosa PI, Fautsch MP (2015) Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems. PLoS ONE 10(11): e0141783 doi: 10.1371/journal.pone.0141783 [DOI] [PMC free article] [PubMed] [Google Scholar]